A furious row has broken out between a drugs company and the NHS regulator in England over the price of a new breast cancer treatment.
Kadcyal which is manufactured by Roche Products Limited can give patients with HER2-positive breast cancer an additional six months of life, but the regulator deemed it too expensive.
ITV News correspondent Nina Nannar reports.
More top news
Selfless Donna Wood from Staffordshire has left her husband and children at home so she can help save lives in Sierra Leone.
From Sierra Leone to Cyprus, 8,500 Christmas boxes were sent out to every serviceman and woman from the UK.
Thousands of people have switched off their Christmas lights as a mark of respect for the victims of the Glasgow bin lorry tragedy.